We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 26 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Aug 06, 2025～Sep 02, 2025
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Aug 06, 2025～Sep 02, 2025
This ranking is based on the number of page views on our site.

  1. 関東化学株式会社 Tokyo//Chemical バイオケミカル部
  2. マーケットリサーチセンター Tokyo//Service Industry
  3. ケーナインラボ Tokyo//Testing, Analysis and Measurement
  4. 4 null/null
  5. 5 カツマタ Shizuoka//Medical and Welfare 医薬品製造販売部
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Aug 06, 2025～Sep 02, 2025
This ranking is based on the number of page views on our site.

  1. For various titrations! The titration "indicator" specified in JIS K8001. 関東化学株式会社 バイオケミカル部
  2. K9 Lab Inc. Company Profile ケーナインラボ
  3. Cavity prevention medicine Gurupepr カツマタ 医薬品製造販売部
  4. 4 Pharmaceutical CDMO services 大塚化学
  5. 4 Global Procurement of Reference Drugs <From Drug Procurement to Problem Solving> キャタレント・ジャパン

medicine Product List

526～533 item / All 533 items

Displayed results
[Research Material] The Global Market for von Willebrand Disease (VWD) Treatments

[Research Material] The Global Market for von Willebrand Disease (VWD) Treatments

World Market for Von Willebrand Disease (VWD) Treatments: Desmopressin, Thrombus Stabilization Drugs, Fibrinolysis Inhibitors, Replacement Therapy, Others, Hospitals ...

This research report (Global Von Willebrand Disease (VWD) Therapeutics M) investigates and analyzes the current status and outlook for the global market of Von Willebrand disease (VWD) therapeutics over the next five years. It includes information on the overview of the global Von Willebrand disease (VWD) therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type for Von Willebrand disease (VWD) therapeutics include desmopressin, thrombin stabilizers, fibrinolysis inhibitors, replacement therapy, and others, while the segments by application target hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments calculate the market size for Von Willebrand disease (VWD) therapeutics by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in Von Willebrand disease (VWD) therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Cancer Anorexia-Cachexia Syndrome Treatment Drugs

[Research Material] Global Market for Cancer Anorexia-Cachexia Syndrome Treatment Drugs

Cancer-related anorexia-cachexia syndrome treatment drugs global market: NEO-1940, C-1889, DLN-101, Foxo1-nRNA, AVG ...

This research report (Global Cancer Anorexia-Cachexia Syndrome Drug Market) investigates and analyzes the current status and outlook for the global market of cancer anorexia-cachexia syndrome treatment drugs over the next five years. It includes information on the overview of the global cancer anorexia-cachexia syndrome treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include NEO-1940, C-1889, DLN-101, Foxo1-nRNA, AVGN-7, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for cancer anorexia-cachexia syndrome treatment drugs. It also includes the market share of major companies in the cancer anorexia-cachexia syndrome treatment drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Postmenopausal Vaginal Atrophy (PVA) Treatment

[Research Material] The Global Market for Postmenopausal Vaginal Atrophy (PVA) Treatment

Postmenopausal Vaginal Atrophy (PVA) Treatment Global Market: Drug Therapy, Other Treatments, Hospitals, Clinics, Others

This research report (Global Postmenopausal Vaginal Atrophy (PVA) Therap) investigates and analyzes the current state and outlook for the global market for postmenopausal vaginal atrophy (PVA) treatment over the next five years. It includes information on the overview of the global postmenopausal vaginal atrophy (PVA) treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for postmenopausal vaginal atrophy (PVA) treatment by type include drug treatments and other therapies, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for postmenopausal vaginal atrophy (PVA) treatment. It also includes the market share of major companies in postmenopausal vaginal atrophy (PVA) treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Vasculitis Treatment Drugs

[Research Material] Global Market for Vasculitis Treatment Drugs

World Market for Vasculitis Treatment Drugs: Brisibimod, CCX-168, Gebokizumab, Rituximab Biosimilar, Others, Nodular Polyarteritis ...

This research report (Global Vasculitis Drug Market) investigates and analyzes the current status and outlook for the global market for vasculitis treatment drugs over the next five years. It includes information on the global vasculitis treatment drug market overview, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Brisibimod, CCX-168, Gebokizumab, Rituximab biosimilars, and others, while the segments by application cover Nodular Polyarteritis, Thrombotic Vasculitis, Granulomatous Vasculitis, Lymphocytic Vasculitis, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for vasculitis treatment drugs. It also includes the market share of major companies in the vasculitis treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Argininemia Treatment

[Research Material] The Global Market for Argininemia Treatment

Global Market for Argininemia Treatment: Oral, Injection, Hospitals, Drugstores, Others

This research report (Global Argininemia Treatment Market) investigates and analyzes the current state and outlook for the global argininemia treatment market over the next five years. It includes information on the overview of the global argininemia treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the argininemia treatment market focus on oral and injectable forms, while the segments by application target hospitals, drugstores, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for argininemia treatment. It also includes the market share of major companies in the argininemia treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Friedrich's Ataxia Treatment Drugs

[Research Material] Global Market for Friedrich's Ataxia Treatment Drugs

Global Market for Friedreich's Ataxia Treatment Drugs: ADVM-063, AGIL-FA, BHV-4157, BVA-202, and others, etc.

This research report (Global Friedreich Ataxia Drug Market) investigates and analyzes the current state and outlook for the global market of Friedreich's ataxia treatment drugs over the next five years. It includes information on the overview of the global Friedreich's ataxia treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include ADVM-063, AGIL-FA, BHV-4157, BVA-202, and others, while the segments by application focus on clinics, hospitals, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Friedreich's ataxia treatment drugs. It also includes the market share of major companies in Friedreich's ataxia treatment drugs, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Pseudomonas Aeruginosa Infection Treatment

[Research Material] Global Market for Pseudomonas Aeruginosa Infection Treatment

Global Market for Pseudomonas Aeruginosa Infection Treatment: Nasal, Oral, Intravenous, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Pseudomonas Aeruginosa Infection Treatment) investigates and analyzes the current state and future outlook of the global market for Pseudomonas aeruginosa infection treatment over the next five years. It includes information on the overview of the global Pseudomonas aeruginosa infection treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on nasal, oral, and intravenous treatments, while the segments by application target hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments calculate the market size for Pseudomonas aeruginosa infection treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in Pseudomonas aeruginosa infection treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Enhancing molecular bonds to protect health!

Enhancing molecular bonds to protect health!

Keywords: glycan, antibody, molecular recognition, multivalent effect, detection reagent

The proverb "When three people gather, the wisdom of Monju" is often heard in our daily lives. Did you know that the power of groups exists even at the molecular level? Glycans facilitate intercellular communication by binding to glycan receptors, but individual glycans have only weak binding strength. However, when multiple glycans come together, their effect far exceeds simple addition, sometimes exhibiting astonishing powers that can be hundreds to hundreds of thousands of times greater. This is called the "multivalency effect." The characteristic of our research is to artificially replicate and further enhance this clever mechanism found in nature. We design artificial molecules that accumulate various molecules, such as glycans and next-generation antibodies, and investigate their interactions in detail. By effectively utilizing the power of molecular cooperation, we hope to contribute to the future of medicine.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.